SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹81,359 Cr | ₹77,225 Cr | ₹66,958 Cr | ₹64,110 Cr | ₹65,077 Cr |
What is the latest Total Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹81,359 Cr |
Mar2023 | ₹77,225 Cr |
Mar2022 | ₹66,958 Cr |
Mar2021 | ₹64,110 Cr |
Mar2020 | ₹65,077 Cr |
How is Total Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹81,359 Cr | 5.35 | |
Mar2023 | ₹77,225 Cr | 15.33 | |
Mar2022 | ₹66,958 Cr | 4.44 | |
Mar2021 | ₹64,110 Cr | -1.49 | |
Mar2020 | ₹65,077 Cr | - |
Compare Total Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹405,169.8 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -0.3% |
-2.9% |
11.5% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses